ERS International Congress, Madrid 2019

Browse by day: Saturday, 28.09.2019 Sunday, 29.09.2019 Monday, 30.09.2019 Tuesday, 01.10.2019 Wednesday, 02.10.2019		View the presentations you missed during Congress! More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.

NELSON: the Trafalgar of lung cancer screening?

Symposium
Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), M. Revel (Paris, France)
Aims: to present NELSON results 1 year after the first data were released, consensus data on participant selection and consensus data on nodule handling to minimise the false positive rate; to discuss the cost-effectiveness of lung cancer screening; to address the ethical dilemma of screening current smokers.

Download all media

Update on NELSON including its cost-effectiveness analysis H. De Koning (Rotterdam, Netherlands)
Screening for lung cancer: who should (not) be enrolled? C. Thomson (Boston, United States of America)
(Not) screening smokers: a patient’s view J. Rawlinson (Tipton, United Kingdom)
How do we handle nodules to minimise the false positive rate? D. Baldwin (Nottingham (Nottinghamshire), United Kingdom)
Introduction on the ESR/ERS statement on low-dose lung cancer screening H. Kauczor (Heidelberg, Germany)